Skip to main content
Premium Trial:

Request an Annual Quote

Arrayjet Expands to US with Cambridge Sales Office

Premium

Edinburgh, UK-based Arrayjet has opened a sales office in Cambridge, Mass., in an effort to meet "increased demand" for its inkjet microarrayers and array manufacturing services in North America, the company said this week.

Arrayjet's commercial director, Claire Jenkins, said in a statement that the company decided to expand its sales team into the US "to support existing and potential new customers" in North America.

Kelda Rawlings, Arrayjet's director of North American sales, will move from Edinburgh to the Boston area to support the US sales office.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.